Race against time: new drug aims to halt brain bleeding in minutes
Disease control
Recruiting now
This study is testing if a drug called recombinant factor VIIa (rFVIIa) can help people who have a stroke caused by bleeding in the brain. The goal is to give the drug very quickly—within 90 to 120 minutes of the stroke starting—to try to stop the bleeding and help patients recov…
Phase: PHASE3 • Sponsor: Joseph Broderick, MD • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC